Dr. Jeffrey Ulmer is the Head of Global Preclinical R&D for GlaxoSmithKline Vaccines. He received his B.Sc. with honors from the Department of Chemistry at the University of Regina in 1978 and was the recipient of the Merit Award of the Society of Chemical Industry of Canada. He received his Ph.D. in biochemistry from McGill University in 1985 and completed his postdoctoral training in the laboratory of Nobel laureate Dr. George Palade in the Department of Cell Biology at Yale University School of Medicine. At Merck Research Laboratories and Chiron Corporation he conducted seminal studies on DNA vaccines, and novel vaccine adjuvants and delivery systems. He has published over 180 scientific articles, is on the editorial boards of Expert Opinion on Biological Therapy and Human Vaccines, and serves on several external advisory boards. Prior to his work with GSK Vaccines, he served as Global Head of External Research at Novartis Vaccines & Diagnostics, responsible for identification and assessment of new opportunities for collaborative research.